Robert F. Kennedy Jr. may soon be America's top pharmaceutical regulator. That is cause for concern in Seattle’s biotech ...

In this opinion piece, Sylvia Wulf, the Biotechnology Innovation Organization’s interim head of agriculture and environment, ...

A Bay Area biotech is suing its insurance company to cover costs associated with patients allegedly injured during clinical ...

Future Food-Tech San Francisco discusses scaling biotech The Future Food-Tech event in San Francisco, which takes place on March 13-14, will dive deeper into the topic of scaling biotech ...

Three recent big-ticket M&A deals have raised expectations the global biotech sector is recovering from its two-year slump.

U.S. Senator Mitch McConnell revealed this week he will chair the Senate Agricultural Subcommittee on Food and Nutrition, ...

Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in ...

Anglia Ruskin University is leading an initiative to identify vulnerabilities and avoid collapse of the UK's food system ...

ITM's lutetium-containing therapy extended progression-free survival versus everolimus in patients with a specific kind of ...

During its Q4 2024 earnings call, Alexandria Real Estate Equities laid out its strategy for a challenging market and praised ...

In an important regulatory win for Denmark’s Novo Nordisk, the US Food and Drug Administration (FDA) yesterday approved ...

The U.S. Food and Drug Administration (FDA) on Thursday approved a new type of prescription pain medication for adults to treat moderate to severe acute pain. The drug, called Journavx (suzetrigine) ...